Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000127556 | SCV000171133 | benign | not specified | 2013-09-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000727457 | SCV000708707 | uncertain significance | not provided | 2017-05-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312591 | SCV000846960 | likely benign | Inborn genetic diseases | 2016-06-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001084800 | SCV001006765 | likely benign | Progressive sclerosing poliodystrophy | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000727457 | SCV001145173 | likely benign | not provided | 2019-06-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000727457 | SCV001149572 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | POLG: BP4, BP7 |